Stock Markets March 20, 2026

BHAV Acquisition Wraps $100 Million IPO, Units Begin Trading on Nasdaq

Special purpose acquisition company raises $100 million through 10 million units; shares and rights set to trade separately once split

By Ajmal Hussain BHAVU
BHAV Acquisition Wraps $100 Million IPO, Units Begin Trading on Nasdaq
BHAVU

BHAV Acquisition Corp completed an initial public offering of 10 million units at $10.00 per unit, raising $100 million. Each unit comprises one Class A ordinary share and one right, with the company depositing the offering proceeds into a trust account. The units began trading on the Nasdaq Global Market under the symbol BHAVU on March 19, 2026; the underlying Class A shares and rights are expected to trade as BHAV and BHAVR after separation. The company said it will use net proceeds to seek and complete a business combination.

Key Points

  • BHAV Acquisition sold 10 million units at $10.00 per unit, raising $100 million, with proceeds deposited into a trust account managed by Continental Stock Transfer & Trust Company.
  • Each unit contains one Class A ordinary share and one right; each right entitles the holder to one-fourth of one Class A ordinary share upon completion of a qualifying business combination.
  • Units began trading on the Nasdaq Global Market as BHAVU on March 19, 2026; once split, the Class A shares and rights will trade under BHAV and BHAVR. Maxim Group LLC served as sole book-running manager and has a 45-day option for up to 1.5 million additional units.

BHAV Acquisition Corp successfully completed its initial public offering with the sale of 10 million units at $10.00 apiece, bringing total gross proceeds of $100 million, the company said in a statement. The offering structure placed the full $10.00 per unit into a trust account held by Continental Stock Transfer & Trust Company acting as trustee.

Each unit contains one Class A ordinary share and one right. The rights carry a fractional entitlement: each right permits the holder to receive one-fourth of one Class A ordinary share should BHAV Acquisition Corp consummate an initial business combination. That fractional-share structure will determine how holders are allocated shares upon completion of a qualifying transaction.

The units started trading on the Nasdaq Global Market under the ticker BHAVU on March 19, 2026. The company said that when the component securities of the units begin trading separately, the Class A ordinary shares and the rights will be listed on Nasdaq under the symbols BHAV and BHAVR, respectively.

Management listed in the filing includes Giri Devanur as Chief Executive Officer and Director and Chaitanya Kumar Setti as Chief Financial Officer and Director. The company stated it intends to deploy the net proceeds of the offering to identify, pursue and complete a business combination with one or more target companies.

Maxim Group LLC acted as the sole book-running manager for the offering. In the underwriting agreement, BHAV granted the manager a 45-day option to buy up to 1.5 million additional units at the public offering price less the underwriting discount to cover potential over-allotments.

Regulatory clearance for the offering came when the U.S. Securities and Exchange Commission declared the registration statement on Form S-1 effective on March 18, 2026. The company was formed as a special purpose acquisition company - a vehicle established to effect a merger, share exchange, asset acquisition, stock purchase or similar business combination with one or more businesses.


Offer mechanics and structure

The offering’s mechanics are straightforward: 10 million units at $10.00 each, with the full proceeds placed in trust and an over-allotment option of up to 1.5 million units exercisable within 45 days. The rights embedded in each unit are fractional, entitling holders to one-fourth of a share upon a completed business combination.

Trading and listing notes

Units trade initially as a bundled security under BHAVU. Once the units are separated, investors should expect Class A shares and rights to trade under BHAV and BHAVR respectively on Nasdaq.

Risks

  • The company’s stated plan is to use net proceeds to pursue a business combination; success in identifying and closing a suitable transaction is uncertain and will determine future value - this impacts investors in the SPAC and potential deal counterparties.
  • The rights attached to units are fractional (one-fourth of a Class A share), which could complicate post-merger allocations depending on how the combination is structured - this affects equity holders and the capital markets activity around the company.
  • The underwriting agreement includes a 45-day over-allotment option for up to 1.5 million units; exercise or non-exercise of this option will change the total capital raised and could influence the company’s available cash for a combination.

More from Stock Markets

EyePoint sues Ocular Therapeutix, alleging false statements about Duravyu and company conduct Mar 20, 2026 Sezzle Replaces Auditor Baker Tilly with PwC for 2026 After Control Weakness Disclosure Mar 20, 2026 US Foods Secures $137.1 Million Defense Supply Contract Mar 20, 2026 Mexican equities fall; S&P/BMV IPC drops 1.63% to one-month low Mar 20, 2026 Aerovironment Secures $135 Million in U.S. Army Orders for Reconnaissance Systems Mar 20, 2026